Additionally, E-selectin antagonists were also shown to prevent hematogenous metastasis of breast cancer via the inhibition of a shear-resistant adhesion of cancer cells to E-selectin-expressing blood vessels on the PMN [291, 292]. The gene discussed is SELE; the disease is breast cancer.